Please login to the form below

Not currently logged in
Email:
Password:

Department of Health

This page shows the latest Department of Health news and features for those working in and with pharma, biotech and healthcare.

Health coverage across state lines

Health coverage across state lines

Additionally, the president asked for greater use of short-term, non-ACA-compliant health plans. ... Retro-sexuality. Through regulatory channels, Trump’s appointees at the department of Health and Human Services (HHS) are giving employers more leeway

Latest news

  • Novartis’ Extavia evades NICE restrictions on MS drugs Novartis’ Extavia evades NICE restrictions on MS drugs

    In what seems to be a hardball play, Carole Longson, director of the centre for health technology evaluation at NICE, said that the agency is "keen to work with the companies ... These drugs were previously available under a risk sharing scheme agreed

  • Ex-GSK head Witty to head group overseeing UK fast-track scheme Ex-GSK head Witty to head group overseeing UK fast-track scheme

    NHS’approval process, which the Department of Health says could mean they reach the market up to four years earlier. ... Despite the innovation happening here, our uptake in the NHS can be too slow, said Health Minister Lord O’Shaughnessy.

  • UK appoints pharma veteran to 'streamline' NHS costs UK appoints pharma veteran to 'streamline' NHS costs

    UK appoints pharma veteran to 'streamline' NHS costs. Steve Oldfield will take up new chief commercial officer role at the Department of Health. ... The UK has recruited pharma veteran Steve Oldfield to fill the newly-created role of chief commercial

  • Mixed news for pharma on UK's Accelerated Access Review Mixed news for pharma on UK's Accelerated Access Review

    The funding includes £39m for Academic Health Science Networks (ASHNs), helping them to assess new health technologies and "support NHS uptake", according to the Department of Health, while £35m in ... funding will be available to the Digital Health

  • NICE gives green light to Ipsen's Cabometyx NICE gives green light to Ipsen's Cabometyx

    Professor Carole Longson, director of the Centre for Health Technology Evaluation at NICE, said: “There are limited treatment options available for people who have advanced kidney cancer, so I am very ... The drug has a list price of £5, 143 per

More from news
Approximately 11 fully matching, plus 677 partially matching documents found.

Latest Intelligence

  • Public affairs

    Healthcare terms - Public affairs.

  • Healthcare systems

    Healthcare terms - Healthcare systems.

  • Not dying of ignorance - 30 years on Not dying of ignorance - 30 years on

    When I arrived at the Department of Health as ministerial press officer seven years later, campaign collateral was everywhere. ... Depeche Mode sang ‘everything counts in small amounts’. For thousands of people alive today, this public health

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    The EMA. The EMA is currently based in London. In February 2017, the health secretary, Jeremy Hunt acknowledged the EMA would leave the UK as part of Brexit. ... There is concern that patients could face delays in accessing new medicines should the UK

  • Lighting the way Lighting the way

    the Department of Health and currently chair of Guy's and St Thomas' NHS Foundation Trust. ... current Patient Access Schemes that pharma companies agree with the Department of Health with input from NICE.

More from intelligence
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest appointments

  • Prof Sir Mike Richards joins Incisive Health as senior counsel Prof Sir Mike Richards joins Incisive Health as senior counsel

    Prof Sir Mike Richards joins Incisive Health as senior counsel. He recently stepped down as chief inspector of hospitals. ... Department of Health, including as national clinical director for cancer for over a decade.

  • LaingBuisson names chairman and CEO LaingBuisson names chairman and CEO

    Stephen Dorrell (pictured right) served as an MP for 36 years and during that time worked as a minister in the Treasury, the Department of National Heritage, and the Department of ... He currently serves as chair of the NHS Confederation and is a senior

  • Judith Moore joins Portland Health Judith Moore joins Portland Health

    From 2007 until 2013, Moore served as the Department of Health's public health media spokesperson, and managed a number of public health campaigns including Change4Life and Stoptober. ... Dr Jane Brearley, partner and head of health at Portland Health,

  • Richard Douglas joins Incisive Health Richard Douglas joins Incisive Health

    Douglas joins after spending almost 40 years in Whitehall, having worked in the Department of Health, HM Customs and Excise, the National Audit Office and National Savings. ... He served most recently as the Department of Health's director general for

  • Former health minister Paul Burstow joins MHP Former health minister Paul Burstow joins MHP

    practice. Rachel Rowson, head of health at MHP Communications, said: “ Paul is an experienced, knowledgeable and well-respected figure within the health and care community, so I am thrilled that he ... During his time at the Department of Health

More from appointments
Approximately 2 fully matching, plus 38 partially matching documents found.

Latest from PMHub

  • The role of pharma in cancer survivorship

    This was initially developed by the National Cancer Survivorship initiative in 2008 by the Department of Health and Macmillan Cancer Support. ... everyone benefits: the long-term recipients of health care, the overburdened NHS, the insurers and payers

  • How will the NHS’s new medicines savings drive affect pharma?

    Although they are frowned on by the Department of Health, Primary Care Rebates are being increasingly used by CCGs to make prescribing budget savings. ... full benefit of expensive drugs, because of lifestyle or health changes, would enable pharma to

  • Can rare diseases be a viable option for the pharma industry?

    Department of Health &Human Services, Office of Inspector General, The Orphan Drug Act – Implementation and Impact, May 2001. ... 36 Biotech / Pharmaceutical companies and 37 patient advocacy groups interviewed by Department of Health &Human Services,

  • Unique forum will unite NHS and industry to drive innovation

    Another key speaker will be Steve Oldfield, the Department of Health and Social Care’ s chief commercial officer and the person charged with renegotiating the £8bn pharmaceutical pricing regulation scheme, who ... industry that’ s required to

  • How can pharma engage with Accountable Care Systems?

    Furthermore, in the past, the effectiveness of drugs has been based on clinical trials. ... This centrally contracted data exploration system from the Department of Health, can, for example, show how a drug is performing across a group of patients and

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Brandcast Health

Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics